Search   |   Print Page   |   Contact Us   |   Sign In   |   Join
Community Search
MassBio Joint Event: The Convergence of Medical Device & Drugs: The Future of Combination Products
Tell a Friend About This EventTell a Friend
 

Combination products continue to be an area of active and exciting development. Clinicians will discuss medical advances. Academic researchers will discuss scientific advances. Entrepreneurs will discuss strategies for funding new combination product ventures. Corporate speakers will discuss the challenges across the value chain of selling combination products globally. Regulatory speakers will address current thinking within government agencies.

5/12/2017
When: Friday May 12, 2017
12-6 PM
Where: Westin Waltham
70 3rd Avenue
Waltham, Massachusetts  02451
United States
Contact: Erica Feinberg
(617) 674-5121

« Go to Upcoming Event List  

 

The Convergence of Medical Device & Drugs: The Future of Combination Products

-

Westin Waltham, 70 3rd Avenue, Waltham MA US 02451

 

 

1) MDG MEMBERS - Click Here for a $100 DISCOUNT LINK (Cost = $150 instead of $250)

[to reach this page, you will be asked to sign-in]

     

2) NON-MEMBERS - Click Here to register on the MassBio Website (Cost = $250)

 

Presented By: 

    

 

Combination products are essential tools for patient care and continue to be an area of active and exciting development. From diffusion based polymer systems to complex delivery devices utilizing diagnostic sensors and sophisticated control systems for precise and timely delivery of life-saving agents, a diverse set of scientific and engineering disciplines are being brought to bear within this space. However, combination products involve components normally developed under different types of regulations, design criteria and controls. This symposium will explore many of the diverse aspects impacting combination products.  

 

Clinicians will discuss the medical challenges for which combination products have provided a unique solution. Academic researchers will discuss scientific advances which may lead to breakthrough products. Entrepreneurs will discuss strategies for funding new combination product ventures, and development issues specific to combination products. Corporate speakers will discuss the challenges across the value chain of selling combination products globally. Regulatory speakers will address current thinking and approaches to combination products within government agencies, both US and internationally.

 

 

Keynote
W. David Lee, CEO, Lumicell Inc.

 

Featured Speakers:

  • Steve Bowman, Device Project Lead, Shire
  • Raina Dauria, Global Regulatory Affairs Leader for Ethicon Biosurgery, Ethicon Inc.
  • David Dykeman, Shareholder & Patent Attorney, Greenberg Traurig, LLP
  • Diane Francis, Senior Director, Health Economic Solutions, Ethicon, Inc.
  • Laura Indolfi, CEO, PanTher Therapeutics, TED Fellow, Entrepreneur in Residence, MGH Cancer Center
  • Raymond Knox, Sr. VP of Manufacturing, Lyndra
  • Peter Markham, MS, President and CEO of CBSET
  • Amar Sawhney, Ph.D., Chairman & CEO, Ocular Therapeutix, Chairman, Augmenix, Inc.
  • Ailis Tweed-Kent, CEO, Co-founder, Cocoon Biotech Inc.
  • Scott Whitaker, President & CEO, AdvaMed

 

AGENDA


Registration & Lunch

12:00 pm

Introductions from MassBio & MDG

Keynote Presentation

12:45 pm - 1:15 pm

Innovation & Development

1:30 pm - 2:45 pm

Break

2:45 pm - 3:15 pm

Commercialization Pathways

3:15 pm - 4:30 pm

Networking Reception

4:30 pm - 5:30 pm

more MDG Calendar

11/16/2017
Special Event: Creating a Great Forum - How to Do It and Why You Should Want To

MDG Premium & Annual Sponsors

 CONTACT


 Medical Development  Group
 POB 555
 Concord, MA 01742

 

 Email:

 MDGBoston@gmail.com

 NAVIGATION 

 

Home

  

 About Us
 Terms of Use
 Privacy Policy

PREMIUM SPONSOR

 

 

   

PREMIUM SPONSOR

 

Association Management Software Powered by YourMembership  ::  Legal